Revelation Biosciences, Inc. stock is down -3.33% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 3 November’s closed higher than October.
Revelation Biosciences, Inc. focuses on the development or commercialization of innate immune system therapeutics and diagnostics. The company's lead therapeutic candidate is REVTx-99, an anti-viral nasal drop for the prevention or treatment of respiratory viral infections.